89bio Inc
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About ETNB
89bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. The Company’s lead product candidate, pegozafermin, a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is being developed for the treatment of metabolic dysfunction-associated steatohepatitis (MASH). Pegozafermin is engineered to protect against proteolysis and reduce renal clearance and optimize its potency, enabling the potential use of a lower dosage/dose. Pegozafermin has been optimally constructed with two mutations via substitutions with natural amino acids at site-specific positions (173 and 176) toward the C-terminus end of the hormone.
Find out what a historical investment in 89bio Inc would be worth today using our ETNB stock calculator.
$1.31B
-
0.00%
7
$9.32
$7.97
$0.00
$11.84
$5.99
Ready to start your investing journey with Stake?
Open an accountETNB FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in ETNB
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in ETNB
on Stake
Buy ETNB from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of ETNB from only US$10 with fractional shares
